www.wallstreet-online.de ·
20816233 soleno therapeutics deadline rosen national investor counsel encourages soleno therapeutics inc investors to secure counsel before deadline securities class action slno
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThis is a securities class action announcement for Soleno Therapeutics (SLNO). No commercial mechanism is identified: no product/commodity price impact, no supply chain disruption, no margin squeeze, no regulatory change affecting operations. The event is a legal proceeding that may affect shareholder value but does not alter the company's revenue, cost, or operational structure. Impact is single-company and limited to legal costs and potential settlement, which are not quantifiable from the article.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Soleno Therapeutics (NASDAQ: SLNO) faces a securities class action lawsuit.
- Class period: March 26, 2025 to November 4, 2025.
- Lead plaintiff deadline: May 5, 2026.
- Rosen Law Firm is encouraging investors to seek counsel.
- Investors may be entitled to compensation on a contingency fee basis.